Device / Heart Failure / Bradycardia · Observational Study

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

ClinicalTrials.gov · August 20, 2026

Preliminary Why this matters to you Expert discussion

Early or partial results. Treat as a signal, not a conclusion.

AI Summary

This is a registry entry for an ongoing observational study sponsored by Medtronic to track long-term performance and lead-related complications in marketed cardiac rhythm management devices. No results have been posted in this registry record, and the study remains in recruitment phase. Clinical professionals cannot base decisions on this record alone.

What was studied

Observational. Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia. Intervention: Device. n = 20,000. 333 sites across 35 countries.

Key findings

Safety

Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.

Who this may help

The source did not state who this applies to in practice.

Plain-language summary

This is a registry record for an ongoing observational study with no reported results; it describes planned enrollment and endpoints only, making it unsuitable for evidence-based clinical decisions.

Study design

As stated by the source record.

MethodsCohort model. Prospective time perspective. Primary outcome measure: Lead related complications for each lead model. (assessed at Ongoing: Implant to the cardiac lead is terminated from the study if the patien…)

DesignObservational

PopulationArrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia

Sample size20,000

InterventionDevice

Setting333 sites across 35 countries

Reported figures

Quoted from the source exactly as published.

Planned enrollment20000

Primary outcome measureLead related complications for each lead model

Study typeOBSERVATIONAL

Caveats

No results are reported in this registry record; study is ongoing.
No comparator group; observational design limits causal inference.
Actual enrollment, follow-up duration, and analysis methods not specified.
Long-term reliability endpoints and survival probabilities not yet available.

Evidence assessment

Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.

Study design

limited

Observational study without control group or randomization.

Directness

moderate

Measures lead-related complications in real-world cardiac device use.

Consistency

insufficient

No results reported; consistency cannot be assessed.

Risk of bias

insufficient

Study ongoing with no results posted; bias assessment not possible.

Sample adequacy

moderate

Estimated 20,000 participants planned; actual enrollment and analysis unknown.

What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.

Source abstract

Registry record from ClinicalTrials.gov (NCT00271180). This is a study registration, not published results. Lead sponsor: Medtronic. Recruitment status: RECRUITING. Study type: OBSERVATIONAL. Enrollment: 20000 participants (ESTIMATED). Conditions: Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia. Interventions: DEVICE: Device. Primary outcome measures: Lead related complications for each lead model. , Ongoing: Implant to the cardiac lead is terminated from the study if the patient exit, patient death, or out-of-service (e.g. deactivated/inactive).. Brief summary: The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.

Follow from this

Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.

NCT00271180DeviceHeart FailureMedtronicBradycardiaArrhythmia